Compare GT & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GT | BLFS |
|---|---|---|
| Founded | 1898 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.3B |
| IPO Year | 2005 | 2013 |
| Metric | GT | BLFS |
|---|---|---|
| Price | $6.24 | $25.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $9.13 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 8.2M | 748.7K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | ★ $18,280,000,000.00 | $96,214,000.00 |
| Revenue This Year | N/A | $19.73 |
| Revenue Next Year | $3.06 | $17.82 |
| P/E Ratio | ★ N/A | $1,318.00 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $5.43 | $17.86 |
| 52 Week High | $11.65 | $29.57 |
| Indicator | GT | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 51.70 | 54.50 |
| Support Level | $6.14 | $23.60 |
| Resistance Level | $6.26 | $26.59 |
| Average True Range (ATR) | 0.26 | 1.36 |
| MACD | 0.09 | -0.20 |
| Stochastic Oscillator | 51.71 | 35.47 |
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific. The majority of its revenue is generated from the Americas business, which develops, manufactures, distributes, and sells tires and related products and services in North, Central, and South America, along with selling tires to various export markets, mainly through intersegment sales.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.